Nottingham Uni Spin-out Secures £7 5m for Heart Disease Study miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Biotech company IsomAb Ltd, whose registered office is at St John’s Innovation Centre in Cambridge, has excited investors with its antibody technology. The company has closed a £7.5 million financing to accelerate its lead candidate to treat peripheral arterial disease.
/PRNewswire/ IsomAb Ltd, a UK-based biotechnology company, announced today the closing of a £7.5 million (approximately US$9.4 million) Seed financing.